production, quality control and biological evaluation of 153sm-edtmp in wild-type rodents

Authors

ali bahrami-samani

mohammad ghannadi-maragheh

amir reza jalilian

simindokht shirvani-arani

moein meftahi

abstract

introduction: nowadays various bone pain palliative therapeutic agents have been developed for bone metastases. among those, 153sm-ethylenediamine tetramethylene phosphonic acid (153sm-edtmp) is the major therapeutic agent which is widely used in the world. in this study, production, quality control and biodistribution studies of this therapeutic radiopharmaceutical have been presented and followed by imaging studies in a wild-type rabbit for the first time in order to make preparations for this agent to be officially approved in the country. methods: 153sm-edtmp was produced using 153sm-smcl3, prepared by neutron activation of an enriched 152sm sample (purity >98%), and in-house synthesized edtmp in 4h at 100°c. the analytical data for the structure determination and purity of the ligand was obtained and shown to be identical to an authentic sample from a european vendor. the radiochemical purity of 153sm-edtmp was checked by rtlc and itlc. the biodistribution of 153sm-edtmp in wild-type rodents was checked and spect imaging as well as following sacrificing the animal. results: the radiolabeled sm complex was prepared in high radiochemical purity (>99%, rtlc) followed by initial biodistribution data with the significant bone accumulation (>70%) of the tracer in 48h which is comparable with the reported methods. conclusion: the produced 153sm-edtmp properties suggest good potential for efficient use of this radiopharmaceutical for bone pain palliation and as substitute for other agents, such as 89srcl2 and 32p, currently used in the country.

Sign up for free to access the full text

Already have an account?login

similar resources

Production, quality control and biological evaluation of 153Sm-EDTMP in wild-type rodents

  Introduction: Nowadays various bone pain palliative therapeutic agents have been developed for bone metastases. Among those, 153Sm-ethylenediamine tetramethylene phosphonic acid (153Sm-EDTMP) is the major therapeutic agent which is widely used in the world. In this study, production, quality control and biodistribution studies of this therapeut...

full text

Sm-EDTMP in Wild-Type Rodents

Introduction: Nowadays various bone pain palliative therapeutic agents have been developed for bone metastases. Among those, Sm-ethylenediamine tetramethylene phosphonic acid (Sm-EDTMP) is the major therapeutic agent which is widely used in the world. In this study, production, quality control and biodistribution studies of this therapeutic radiopharmaceutical have been presented and followed b...

full text

Production, quality control and biological evaluation of 153Sm-TTHMP as a possible bone palliation agent

Introduction: Various bone palliative therapeutic agents have been developed and widely used for bone metastasis such as 153Sm-EDTMP. In this study, production, quality control and biodistribution studies of a newly developed therapeutic compound have been presented followed by imaging studies in wild-type rodents. Methods: 153Sm-TTHMP was prepared starting from 153<...

full text

production, quality control and biological evaluation of 153sm-tthmp as a possible bone palliation agent

introduction: various bone palliative therapeutic agents have been developed and widely used for bone metastasis such as 153sm-edtmp. in this study, production, quality control and biodistribution studies of a newly developed therapeutic compound have been presented followed by imaging studies in wild-type rodents. methods: 153sm-tthmp was prepared starting from 153sm-smcl3, prepared by neutro...

full text

Production, Quality Control and Biological Evaluation of 166Ho-PDTMP as a Possible Bone Palliation Agent

Objective(s):In this study, 166Ho-1,2-propylene di-amino tetra(methy1enephosphonicAcid) (166Ho-PDTMP) complex  was prepared as a bone palliation agent. Materials and Methods:The complex was successfully prepared using an in-house synthesized EDTMP ligand and 166HoCl3. Ho-166 chloride was obtained by thermal neutron irradiation (1 × 1013 n.cm-2.s-1) of natural Ho(NO3)3 samples  followed by radio...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of nuclear medicine

Publisher: tehran university of medical sciences

ISSN 1681-2824

volume 17

issue 2 2009

Keywords
[ ' s m ' , 1 5 3 , ' e d t m p ' , ' r a d i o p h a r m a c e u t i c a l ' , ' t h e r a p y ' , ' b i o l o g i c a l e v a l u a t i o n ' ]

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023